-
- General Topic: INTEQUAN Software
- Youtube link: To be provided
- Presenter(s): Henning Schmidt
- Date: June 02, 2017
- Location: Online
- Time: 12:30 to 13:05 EST
- Background Resources for t…
-
https://www.ncbi.nlm.nih.gov/pubmed/28391404
Dallmann A1, Ince I2, Solodenko J3, Meyer M4, Willmann S4, Eissing T5, Hempel G1.
Abstract
BACKGROUND:
Since pregnant women are considerably u…
-
Hello everyone,
My name is Andy Kim and I am currently a master's student in Dr. Maharaj's lab in the Faculty of Pharmaceutical Sciences. The primary focus of our lab is physiologically-based pharm…
-
NONMEM data sets usually contain information about dosing events (dose + dosing time), formulation GFR, and a lot of biometric information of the study subjects, etc.. It would be great to enable PK-S…
-
https://www.ncbi.nlm.nih.gov/pubmed/31489678
J Clin Pharmacol. 2020 Feb;60(2):240-255. doi: 10.1002/jcph.1515. Epub 2019 Sep 6.
Liu XI1, Momper JD2, Rakhmanina N1,3, van den Anker JN1,4,5, Green DJ6…
-
Hello
I am trying to build a pregnancy model that I started in PK-Sim, sent to MoBi
Then in MoBi I did the following all the steps advised in "Applied Concepts in PBPK Modeling: How to Extend an O…
-
https://www.ncbi.nlm.nih.gov/pubmed/24283665
Br J Pharmacol. 2014 Feb;171(4):1043-53. doi: 10.1111/bph.12533.
Abstract
BACKGROUND AND PURPOSE:
In vitro inhibitory potency (Ki )-based pred…
-
https://www.ncbi.nlm.nih.gov/pubmed/28924743
Clin Pharmacokinet. 2017 Sep 18. doi: 10.1007/s40262-017-0594-5.
Dallmann A, Ince I, Coboeken K, Eissing T, Hempel G.
Abstract
BACKGROUND:
P…
Incei updated
3 years ago
-
https://pubmed.ncbi.nlm.nih.gov/32451908/
Liu XI, Momper JD, Rakhmanina NY, Green DJ, Burckart GJ, Cressey TR, Mirochnick M, Best BM, van den Anker JN, Dallmann A. Prediction of Maternal and Fetal Ph…
-
Hi Wang Wei, I saw your simulation on carvedilol for (Manuel Ibarra, Cristian Valiante, Patricia Sopeña, et al. Integration of in vitro biorelevant dissolution and in silico PBPK model of carvedilol t…